Latest common stock for ESALF: $45B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.
As of the most recent data (December 2022), ESALF shows a common stock of $45B. That compares with $45B in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, ESALF's common stock is now $45B (was $45B) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Eisai , Ltd. is outperforming or lagging.
Tracking ESALF's common stock over time shows whether Eisai , Ltd. is scaling, shrinking, or reshaping that part of the business. The current reading is $45B That compares with $45B in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this common stock page, Stockcircle has Eisai , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $45B) with ownership activity and broader fundamentals.
Eisai , Ltd.'s common stock is $45B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.